Medical/Pharmaceuticals

Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner

VISTA, California, Oct. 31, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack load...

2019-10-31 06:00 406

Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution

PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...

2019-10-31 04:05 5199

GC Pharma Reports Q3 2019 Results

YONGIN, South Korea, Oct. 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedSeptember 30, 2019. Key Figures Q3 2019(1) Growth(1) Total revenues K...

2019-10-30 21:00 5210

New NCCN Guidelines Debut to Manage Complications and Improve Readiness for Stem Cell Transplant Recipients

National Comprehensive Cancer Network expands resources to meet growing utilization of cell-based cancer treatments PLYMOUTH MEETING, Pennsylvania, Oct. 30, 2019 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®) published new NCCN Clinical Practice Guidelines in Oncology ...

2019-10-30 20:30 378

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases

GERMANTOWN, Maryland, Oct. 30, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (fka Neuralstem, Inc.) (NASDAQ: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., aChina-based company focused on m...

2019-10-30 19:00 3300

EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay

SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™  (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) withFLT3 mutations (FL...

2019-10-30 18:00 354

AI Medical Technology Enters "One Belt, One Road" Initiative; Ping An Good Doctor Attends 3rd Future Investment Initiative

SHANGHAI, Oct. 30, 2019 /PRNewswire/ -- The third edition of Future Investment Initiative (FII) began inSaudi Arabia's capital Riyadh on 29 October. The world's leading online healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; stock code: 0183...

2019-10-30 13:57 3510

World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer

More than 80 organizations from 30 countries to advocate for early diagnosis of pancreatic cancer onThursday, Nov. 21 MANHATTAN BEACH, California, Oct. 30, 2019 /PRNewswire/ -- Pancreatic cancer has the lowest survival rate among all major cancers because few people know the risks and symptoms a...

2019-10-30 05:47 346

NeoDynamics Receives Regulatory Approval for new Breast Cancer Biopsy System

STOCKHOLM, Oct. 30, 2019 /PRNewswire/ -- NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version. The upgraded pulse biopsy system includ...

2019-10-30 00:13 449

Effect of Climate Change on the Brain, Link to Alzheimer's and Parkinson's, to be Key Focus of Discussion at XXIV World Congress of Neurology

DUBAI, United Arab Emirates, Oct. 29, 2019 /PRNewswire/ -- World Federation of Neurology -- Breakthrough studies indicate that the impact of air pollution and rising incidents of stroke, Parkinson's and other neurological diseases are potentially linked. The environmental impact of climate change...

2019-10-29 21:53 412

WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, inDusseldorf, Germany at Stand Hall 1...

2019-10-29 21:00 268

New Study in Hong Kong Shows Home Ambulatory Chemotherapy Improves Cancer Patient's Quality of Life

HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Quality of life is an important aspect of a cancer patient's treatment journey. Hong Kong Society of Clinical Oncology today announced the findings from a recent research study inHong Kong, which shows that home ambulatory chemotherapy can improve cancer p...

2019-10-29 16:52 385

Amaris B. Clinic Reveals Health Benefits of VASER Liposuction

SINGAPORE, Oct. 29, 2019 /PRNewswire/ -- According to a compelling clinical study titled "Strategies For Reducing Body Fat Mass: Effects Of Liposuction And Exercise On Cardiovascular Risk Factors And Adiposity. Diabetes, Metabolic Syndrome And Obesity: Targets And Therapy"[1] by Benatti et al., ...

2019-10-29 14:43 311

Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit

GERMANTOWN, Maryland, Oct. 29, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (fka Neuralstem, Inc) (NASDAQ: CUR) a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will present at the 7th China Renaissance Healthcare and Life Sciences Leaders...

2019-10-29 13:17 2556

European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma

Not intended for US, Canada and UK-based media  -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with BAVENCIO in combination with axitinib compared with sunitinib -- Combination regimen approved across all IMDC prognosti...

2019-10-29 02:00 415

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...

2019-10-28 20:30 2559

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 28, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-28 08:38 365

WuXi STA's Jinshan Facility Passes EMA Inspection

SHANGHAI, Oct. 28, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announced today that its Jinshan manufacturing facility inShanghai, China has successfully passed an inspection by the European Medicines Agency (EMA) with no critical and no major fin...

2019-10-28 08:00 379

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 26, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-26 19:00 502

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences.  During the Festival of Biologics confere...

2019-10-26 18:01 577
12345678 ... 356